Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-017898
Filing Date
2014-12-10
Accepted
2014-12-10 17:05:13
Documents
2
Period of Report
2014-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2257
2 schorpoa.txt EX-24 3981
  Complete submission text file 0001179110-14-017898.txt   7444
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Schor Chen (Reporting) CIK: 0001340875 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 141278660